Conference Information

Welcome Message

Pulsus welcome you to join us at “7th European Virtual Congress on Pharmaceutical Sciences” on “February 14-15, 2022”, conducted by organizer committee and moderators in collaboration with academics and industrialists, held as a webinar. This year Pharma 2022 is based on “Exploring the Prospers of Drug Development, Safety and its Scientific Report”. The theme of this event is to explore an outstanding opportunity to co-operate world-class professionals and researchers in organisations, universities and business sector with diligent persons across the overseas.

A showcase for posters and video presentations, brand establishment, workshops for marketing your sector ideas and research innovations.

We are looking forward for your participation to an excellent meeting with professions from different countries and sharing their views and ideas in Pharma 2022.

If you have any queries you can drop us a mail to europharmasummit@pulsusseries.com .

Regards
Organizing Committee
Pharma 2022

About Conference

On behalf of Pulsus, we welcome you all for the “7th European Virtual Congress on Pharmaceutical Sciences”, scheduled on February 14-15, 2022 as a webinar. At PHARMA 2022, learn about the Pharma revolution and its view on industries and research organisations.

We will be having seminar and discussion panels. Awards and certificates will be given by our organizing meeting committee.

This conference gives you a best opportunity to upgrade your career level by meeting a large number of participants from Pharmaceutical Sector.

Why to Attend?

Be the person to connect with variety of Global Pharmaceutical Market. Join the Pharma Conference, the world's largest Toxicology Conference and Gathering for the Research Community for Pharmacology Sector. Gather new instinct activities from plenary speakers, poster presentations and workshops programmes by encouraging them to motivate for business leads in Pharma.

To Meet Experts of Pharmaceutical Market
Enhance Learning of New Tips & Tactics
Certifications
Demonstrate your publications
Explore Apps and Development of Healthcare
Brand Exhibition

Why Pharmaceutical Sciences 2022?

Innovators of Pharmaceutical Science and Health Care Professionals are reserving as vanguard rescuers of the world in this pandemic COVID-19. The Pharmaceutical Sciences emerged as an interest between pharmaceutical industries and research organizations for public health.

The Pharmaceutical sector comprises of designing antibiotics, therapeutic solutions, traditional drugs, nutraceuticals, cosmeceuticals, immune-oncology targets, tissue engineering and regenerative medicine, prophylaxis of disease, preventive healthcare, innovative prognostic solutions, sustainable bio-products, and genome-based diagnostics and research solutions. Healthcare expenditure has enabled targets surrounding drug discovery in clinical trials, clinical examiners, development of biomedical application for diagnosis and treatment in academics, marketing and manufacturing industries generation. It promotes a wavier health and safety for the conservative and improvement in quality of life.

Outlook of drug development occurring each day.
Bending to the factors of threatening diseases and rehabilitating the world with new and alternative options for diagnosis and treatment.
Patient care goals - a SMART objective.
Adequate academic credentials and entrepreneur ideas.
Expanding growth sector from students to Industrialists.

Your presence has the following merits:

Win Awards and Certificates, as recognition for your abstracts to encourage the groundwork of your projects.
‘Speakers, Delegates, Young Research Forums, Exhibitors’ to establish your work with project developers in Industries and Government agencies. Summit your abstracts with the given Template (https://pharma.pulsusconference.com/conference-brochure)
“Advertise with Us”
Unique opportunity for entrepreneurs as Advertisers and Sponsors for Congress Pharma 2022..

Scientific Sessions and Tracks

Session 1: Bio-Technology Therapeutics and Diagnostics

Bio-technology serves a commercial success and stunning growth in the productive evolution of research and development and in revenue of industries. The bio-tech industry is flourishing in such a way, that it has dramatically changed the tedious development of drug target and validation to an instant rapid and fascinating process. It is aimed at focussing R&D and innovations of life science software. Biotechnology market size was rated at 752.88 billion USD in 2020 and is expected to expand 15.83 % annually from 2021 to 2028, with an expansion of developing and managing several risks in the world.

Session 2: Pre-Clinical and Clinical Trials

Practitioners of pre-clinical and clinical trials have become the standard scientific standards for evaluation of therapeutic global solutions. Pre-Clinical Trial focuses on greater aspects of identification and validation of ‘Drug and Target’, while Clinical Trial focuses on drug regimen and vigilance for the global health.

Session 3: Drug Formulations and Development

Clinical preliminaries give a dynamic way to deal with medication improvement and exchange ideas and knowledge between safety and complexity of the novel diseases. Formulation development is a fundamental factor in the present and future of investigating the medicinal product. Till this year, an over-count of 500,000 drugs has been developed for therapeutics. Escalation focus of Pharmaceutical Sciences in the development of New Chemical Entities, Sustainable Release Tablets, Pro-Drugs and Probiotics, Nano-medicines, Combination and Modifications In API In Drug Formulation, Vaccine Production, Nutraceuticals and Cosmeceuticals and Animal Health Products

Session 4: Bio-pharmaceutics & Clinical Pharmacokinetics

Bio-pharmaceutics & Clinical Pharmacokinetics have revolutionized in the field of drug formulations and abounding development in the era of challenging public health. The Bio-Pharmaceutics market has projected to expand its common annual growth at a rate of 8.3 % from 2018 to 2025, having an expanding sector of 3000 Pharma companies and wide ranging research institutes.

Session 5: Pharmacovigilance

Pharmacovigilance: A trustworthy quality and competence is critical to solve in the field of pharmaceutical sector. To overcome this, and due to Thalidome incident, there emerged this Pharmacovigilance, a field to detect, verify, assess and prevent the drugs causing actions used for treatment and diagnosis or for any non-medication purpose. Perhaps the most interesting part is, the programmers developed tools and software where an individual can register his or her complaints, so the Adverse Effects and Benefit-Risk Ratio of the given medication can be calculated instantly, and this is helpful in targeting the correct medication in the vaccine development during this COVID-19 pandemic.

Associations on Pharmacovigilance: BioHarmony Data Simplified | ORACLE | VigiMed | Fifth Board of Anvisa | Sanofi Pasteur | Ministry of Health and Prevention – SPAIN || European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association| Chinese Biopharmaceutical Association | Pharmaceutical Society of Australia | Pharmacy Guild of Australia | Chinese American Biopharmaceutical Society.

Session 6: Toxicology Studies

Basic principles, hypotheses, and explanations relevant to the effects of chemical concentration, dosage, and toxicity on risk, as well as the importance of animal experiments in predicting the effects of chemicals on humans, are the focus of toxicology. As part of non-clinical research studies of pharmaceuticals, animal tests for toxicity have been performed prior to and in conjunction with human clinical investigations. The response of xenobiotics to toxicology evaluation tests was studied. The poisonous effects of a chemical or other material on different organisms at various amounts contribute to an environmental hazard.

In debates regarding toxicology-related threats, myths that scientists can aim to explain in communications with the public and media may play a key role. Toxic kinetics is the term for the study of all compounds' kinetics at toxic doses and exposure thresholds. Current recent research update indicate that significant progress should be expected in the fields of pharmacokinetics and toxic kinetics for assessing drug-drug interaction and food-drug interaction metabolism.

Session 7: Challenges for Healthcare Professionals

Toughest health challenges are done under the auspices of the researchers and Health care Professionals. The past year has been an unmanageable situation for the Health care Professionals. This lead a complexity condition, how to overcome the capacity management for present and future unexpected high-quality care to all patients. The significant challenges for healthcare professionals include understanding the diseases, helping the suffering patients and preventing the spread of the disease and they have their tasks to reassure and achieving wide spread immunity to the patients. All decisions of reviewing medical products are deliberate process is done by medical practitioners and create survey reports based on their reviews.

Session 8: Social Pharmacology

The urge for development of medications caused an action for eradicating the novel diseases. However, the public health is guarded by these developments, there executes some complexities and contraindications for the environment. Medicinal alert to protect patients and analyzing the side to side effect of the medicines for treatment or diagnosis or other non-therapeutic products had become a goal for the healthcare. Concern for arising risk and arguments in development claims undesired situations globally. These situations should be carefully monitored and solutions should be provided overseas by the governing authorities of the sectors.

Session 9: Pharma Entrepreneur

Entrepreneurs ingrained the art of innovation in pharma and to establish entrepreneurship ideas to an extreme scale. They have been dogged with high risk of planning, good decisions and great mentors in Pharma establishment. This impact leads to growth of wide scale of entrepreneurial vision in fields of proteomics, genomics and vigilance.

Session 10: Technology Advances in Life Science

The development of robust database in pharmaceutical sciences paved a way to tackle the complicated bureaucratic landscape of pharma. Collaborative innovation of various life sciences companies lead to the advancement in drug research. This increased volume of life science researchers has opened up solutions for new challenges for creating products to improve the lives of organisms and exploring opportunities in pharmaceutical sector. The life science market is expected to hit around US$ 95.68 billion by 2027. The market size of cancer biomarkers was estimated as $26,979.50 million by 2027, with CAGR 11.8%.

Session 11: Computational Biology

The large-scale advancement of computational methods and bioinformatics research projects made possible to tackle the problems like duration in drug discovery, pandemic drastic and complexity effects and emerging biological mysteries. European Research Council (ERC) has invested more than 700 million euros in computational biology and gave a hand of 350 projects in computational biology.

Session 12: Pharmaceutical Industry

Pharma profits are generated due to their targets in the therapeutic demand for the public health. They face issues in major challenges in demand more or less of blockbuster drugs, unexpected changes in dynamic care, developing new novel ideas, managing consolidation and competitions among sectors. The pharmaceutical industry is valued totally at 1.25 trillion U.S. dollars in 2019. 43 therapeutics companies helped for performing Phase II trial for COVID-19. The companies involved are AstraZeneca, Applied Therapeutics Inc., 4D Pharma plc and many other companies.

Session 13: Pharma Pricing & Market Analysis

Due to the exuberating advances in Pharma demanded a role in rapid growing exports of drugs and medicines. Investment in research and drug manufacturing embedded in a network of urge for suppliers and stock markets. The pricing of drugs faces fewer environmental regulations leading to alterations in pharma market. Testimony of risk to benefit monitoring guaranteed a way to efficient usage of medications.

Session 14: Bio-Electrodynamics

Computational Modelling for Drug Development against Novel Diseases
Tools to Analyse Electromagnetic Properties between molecule level to tissues
Microtubule Electro properties
Molecular Modeller Approaches and Techniques
Mechanisms of Protein Machinery
Advances in Super-Resolution Microscopy
Interaction and Dependence of Photon light-matter interaction
Microfluidic Electric spectroscopy

Session 15: Global Artificial Intelligence in Drug Discovery Market

Development of computer technology basically requires human intelligence for preforming tasks. It is a machine learning process which includes tasks such as algorithm of mathematical concepts, visual perception, motion tracking, analytics, translating, and speech recognition. Artificial Intelligence application in healthcare involves in individual case safety processing, diagnosis and treatment analysis, changing the people ways in their health needs. Achieve trustworthy. Predicting disease and providing solutions for development of drugs in global pandemic. However, implementation factors of AI will have a limited job loss of healthcare professional jobs for a considerable period. It is suggested that 35% of UK jobs will have a lay-off by the existence of AI, over the next 10 to 20 years. In life science, even though AI achieves a trustworthy outcome, in some cases its algorithm approaches are impractical in problem-solving of trial and error methods.

Submit Abstracts on

Market Analysis of Pharmaceutical Science

In the pharmaceutical industry, the focus is increasingly on cell therapies, clinical research, biomedicine, medical software, clinical testing software, vector-based technologies, bio-reagents, synthetic proteins, antibodies, and medical devices. Through various mergers and acquisitions, pharmaceutical associations are expanding their borders. As a result of increasing demand for temperature-sensitive pharmaceutical drugs, a booming biopharmaceutical industry in the Asia Pacific, and several other factors driving the market, the market is expected to grow during the forecast period.

Global pharmaceutical air trade grew by more than double from 2000 to 2016. The organizations have invested more than € 1.2 billion in 2009 in pharmaceutical and biotechnology companies' (Phase IIb / III) clinical trials, Pharmacovigilance, and environmental management, and animal health. Innovation and development can be accomplished through research and development, commerce, technology transfer, and collaboration.

A rapidly evolving threat is impacting businesses, communities, and industries around the world as a result of COVID-19's emergence. As a result of the researchers' work, vaccines and therapeutics have become available, supporting market recovery and growth. Approximately USD 38,213.3 million of clinical trials market revenue was generated in 2020, and it is expected to reach USD 51,356.0 million by 2026, registering a CAGR of 5.05% for the forecast period, 2021-2026.

CROs are increasingly used for conducting clinical trials in the pharmaceutical sector due to their diversified expertise and the use of advanced technologies. The industry will benefit from the domino effect due to the continuous learning and innovation, resulting in a 50-70% increase in trial access and efficiency, which will provide more access to more effective therapies for more people globally. Digitalization is also paving the way for market growth in biomedical research.